SLC22A12 and hyperuricemia: The main advantage of our study was primarily its detailed genetic analysis of urate transporters GLUT9, URAT1, and the previously analyzed ABCG2 in a clinically and biochemically characterized cohorts of Czech patients with primary hyperuricemia and gout.